IL-21 peptides and nucleic acids

The invention relates to an IL-21 polypeptide having the sequence of residues 30-162 of IL-21 and nucleic acid encoding such polypeptides. Also disclosed is the formulation of pharmaceutical compositions comprising an IL-21 polypeptide and the treatment of conditions where eosinophils are involved i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MOELLER, NIELS, PETER, HUNDAHL, SKAK, KRESTEN, ROEMER, JOHN
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to an IL-21 polypeptide having the sequence of residues 30-162 of IL-21 and nucleic acid encoding such polypeptides. Also disclosed is the formulation of pharmaceutical compositions comprising an IL-21 polypeptide and the treatment of conditions where eosinophils are involved in a protective response, e.g. allergic reactions, allergic diseases and parasitical diseases.